WorldSmart: The Impact of Export Control and Economic Sanctions on International Business
Podcast: President Biden's Use of the Defense Production Act - Diagnosing Health Care
What Can Businesses Do After Texas Lifts the Mask Mandate?
#WorkforceWednesday: OSHA’s Updated COVID-19 Guidance, CDC’s New Mask Guidance, Biden Administration Rollbacks - Employment Law This Week®
Slamming the door on 2020 and looking ahead to 2021
Supporting Health Through Supply Chain Management
Barry Ostrowsky on The Future of Health Care: Health Care Delivery and Consolidation Trends in 2020 and Beyond - Diagnosing Health Care Podcast
Labor & Employment Podcast Series: Enforcement of Face Coverings
Rules of the Road: Return to Work in the Time of COVID-19
#WorkforceWednesday: First Workplace Safety Mandates, COVID-19 Employee Training, Masks Required at Major Retailers - Employment Law This Week®
Blakes Continuity Podcast: Life Sciences: Liability and Immunity During COVID-19
#WorkforceWednesday: OSHA Urges Face Masks, ADA Turns 30, Employee Vacations - Employment Law This Week®
Blakes Continuity Podcast: Entering the COVID-19 Marketplace: Proceed with Care
A Conversation with Elite Sportswear: COVID-19 Client Stories
Manufacturing Masks and Protective Equipment in the Age of COVID-19: Troutman Sanders and Pepper Hamilton COVID-19 Litigation Podcast Series
More Emerging Litigation Claims and Demands from COVID-19
On May 14, 2024, the Biden administration announced expansions to the United States’ Section 301 tariffs on imports from China, proposing to raise tariffs on solar panels, electric vehicles, batteries, green energy supply...more
The COVID-19 pandemic presented the U.S. Food and Drug Administration (FDA or Agency) with a monumental task of shifting its operations and the way it approached the regulation of critical drugs, medical devices, and biologic...more
On December 22, 2021, the Food and Drug Administration (FDA) published draft guidance documents for manufacturers of devices that were issued Emergency Use Authorizations (EUAs) or were subject to relaxed enforcement policies...more
The Food and Drug Administration (FDA) is a consumer protection agency that ensures the safety and efficacy of certain products in the US, such as medical devices, drugs, and prescriptions, tobacco products, cosmetics, food,...more
LATEST KEY DEVELOPMENTS Competition & State Aid • EU General Court annuls COVID-19-related State aid decisions for inadequate reasoning • European Commission receives Recovery and Resilience Plans from 23 Member...more
LATEST KEY DEVELOPMENTS Competition & State Aid • Portugal is first Member State to officially deliver Recovery and Resilience Plan to European Commission • EU Single Resolution Board responds to European...more
LATEST KEY DEVELOPMENTS Competition & State Aid • Launch of Multilateral Working Group of leading competition authorities to assess the effects of mergers in the pharmaceutical sector, including drug pricing •...more
At the beginning of the COVID-19 pandemic, we saw what seemed to be a surplus of “FDA Registration Certificates” being presented by Chinese manufacturers of face masks and other personal protective equipment (PPE) as evidence...more
In 2020, heightened demand for health care resulted in an influx of therapeutic goods being included on the Australian Register of Therapeutic Goods (ARTG). A large portion of these goods are manufactured in China however,...more
LATEST KEY DEVELOPMENTS Competition & State Aid • European Commission pursues Fit for Future Platform to simplify EU law, including in the area of State aid, particularly in response to the pandemic • EU approves new...more
In the past week, President Biden signed the American Rescue Plan, which provides $10 billion to expand domestic production of medical supplies. The President also announced that all adults in the U.S. will be eligible for...more
The pandemic year of 2020 presented FDA with many enormous challenges, including how to use emergency authorizations to approve diagnostic tests, personal protective equipment, and therapies, how to conduct remote...more
Companies holding intellectual property in medical products used in the fight against COVID-19 should be aware of formal efforts by a group of nearly 60 developing countries, led by India and South Africa, to obtain a waiver...more
LATEST KEY DEVELOPMENTS - Competition & State Aid • European Commission launches public consultation on revision of IPCEI Communication • EU approves new and amended Member State measures to support the economy ...more
In an effort to stimulate safe reopening of the economy and protect companies acting in good faith, Indiana has enacted a COVID-19 immunity shield. Governor Eric Holcomb signed Indiana Senate Bill 1, “Immunity Related to...more
This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. LATEST KEY DEVELOPMENTS -...more
Competition & State Aid • EU approves new and amended Member State measures to support the economy Trade / Export Controls • EU and India launch the High-Level Dialogue on Trade and Investment, with a particular...more
LATEST KEY DEVELOPMENTS - Competition & State Aid • European Commission launches public consultation on fair taxation in the digital economy • European Commission proposes to further prolong and adjust State aid...more
LATEST KEY DEVELOPMENTS Competition & State Aid • EU approves new and amended Member State measures to support the economy Trade / Export Controls • European Commission announces export transparency mechanism...more
LATEST KEY DEVELOPMENTS - Competition & State Aid • €25 billion Pan-European Guarantee Fund deployed for the first time • EU approves new and amended Member State measures to support the economy Trade / Export...more
LATEST KEY DEVELOPMENTS - Competition & State Aid • European Commission addresses State aid support in Communication on tackling nonperforming loans in the aftermath of COVID-19 pandemic • European Commission...more
This regular update (no. 29 | 15 December 2020) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal...more
LATEST KEY DEVELOPMENTS - Competition & State Aid • EU approves new and amended Member State measures to support the economy • Executive Vice-President and Competition Commissioner Vestager speech on the future of State...more
LATEST KEY DEVELOPMENTS - Competition & State Aid • EU approves new and amended Member State measures to support the economy • European Commission Executive Vice-President Margrethe Vestager speech on COVID-19 State...more
This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. LATEST KEY DEVELOPMENTS...more